We are live on ! Find out more
USNA icon

Usana Health Sciences
USNA

131 hedge funds and large institutions have $611M invested in Usana Health Sciences in 2014 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 55 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 19

32% more capital invested

Capital invested by funds: $463M → $611M (+$149M)

6% more funds holding

Funds holding: 124 → 131 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.29% less ownership

Funds ownership: 97.13% → 96.84% (-0.29%)

44% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 55

Holders
131
Holders Change
+7
Holders Change %
+5.65%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
31
Reduced
55
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$9.57M
2
BIM
Bogle Investment Management
Massachusetts
+$7.68M
3
Millennium Management
Millennium Management
New York
+$7.42M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.85M
5
Two Sigma Investments
Two Sigma Investments
New York
+$6.57M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$47M
2
LSV Asset Management
LSV Asset Management
Illinois
-$15.6M
3
WA
Wasatch Advisors
Utah
-$5.79M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$5.51M
5
BGIM
Brandywine Global Investment Management
Pennsylvania
-$4.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$4M -$5.51M -112,318 -59%
Allianz Asset Management
27
Allianz Asset Management
Germany
$4M -$86.3K -1,758 -2%
Goldman Sachs
28
Goldman Sachs
New York
$3.98M -$1.01M -20,602 -21%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$3.87M +$2.57M +52,400 +227%
Charles Schwab
30
Charles Schwab
California
$3.83M +$1.29M +26,266 +54%
SAM
31
Shell Asset Management
Netherlands
$3.72M – – –
ETM
32
Euclidean Technologies Management
Washington
$3.56M -$1.83M -37,336 -35%
PPA
33
Parametric Portfolio Associates
Washington
$3.55M -$389K -7,932 -10%
Invesco
34
Invesco
Georgia
$3.3M +$2.82M +57,442 +843%
CS
35
Credit Suisse
Switzerland
$3.05M +$2M +40,652 +215%
MCM
36
Matarin Capital Management
New York
$2.91M +$51.1K +1,040 +2%
Fiera Capital (Canada)
37
Fiera Capital (Canada)
Quebec, Canada
$2.64M -$687K -14,000 -21%
HA
38
Heartland Advisors
Wisconsin
$2.56M -$3.58M -72,874 -59%
PAM
39
Paradigm Asset Management
New York
$2.56M +$2.46M +50,000 New
CEI
40
Clark Estates Inc
New York
$2.44M -$717K -14,600 -24%
PAM
41
Panagora Asset Management
Massachusetts
$2.38M -$2.12M -43,116 -48%
DC
42
Deere & Company
Illinois
$2.33M +$1.01M +20,600 +83%
GCP
43
GSA Capital Partners
United Kingdom
$2.29M -$157K -3,200 -7%
TCIM
44
TIAA CREF Investment Management
New York
$2.29M -$235K -4,786 -10%
CIA
45
Capital Impact Advisors
Massachusetts
$2.19M – – –
HI
46
HBK Investments
Texas
$2.1M +$2.01M +41,000 New
SFM
47
Systematic Financial Management
New Jersey
$2.08M -$1.18M -23,960 -37%
UFF
48
USA Financial Formulas
Michigan
$2.06M +$1.97M +40,176 New
PP
49
PDT Partners
New York
$2.04M -$354K -7,200 -15%
WBC
50
Westpac Banking Corp
Australia
$1.98M -$1.36M -27,792 -42%
1
2
3 4 5

USNA Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2014, worth a combined $611M — up 32% from $463M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new USNA positions and 19 closed out — a net gain of 10 holders — while 31 added to existing stakes and 55 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $9.57M. The largest seller was Fidelity Investments, cutting an estimated $47M.

  • 131 institutional investors held Usana Health Sciences (USNA) as of Q4 2014, up from 124 in Q3 2014.
  • Funds reported $611M of Usana Health Sciences stock for Q4 2014, up 32% quarter-over-quarter.
  • 29 funds opened new Usana Health Sciences positions in Q4 2014 and 19 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q4 2014 was Renaissance Technologies, an estimated $9.57M added.
  • The largest Usana Health Sciences seller in Q4 2014 was Fidelity Investments, an estimated $47M sold.

Based on aggregated 13F filings for Q4 2014.